Hyperlipidemia
📧 Sign up to get email alerts when something new happens for Hyperlipidemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-03-10FDA Approved: COLESTIPOL HYDROCHLORIDE — Original Application (Zydus Lifesciences Limited)
FDA approves a generic version of Colestipol Hydrochloride under an Original Application filed by Zydus Lifesciences Limited.
-
FDA approval · 2022-03-07FDA Approved: ZOCOR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for ZOCOR (simvastatin) submitted by Organon LLC.
-
FDA approval · 2022-03-03FDA Approved: NIACIN — Original Application (Macleods Pharmaceuticals Limited)
FDA approved the original application for NIACIN (nicotinic acid) from Macleods Pharmaceuticals Limited, establishing a generic version of t…
-
CLINICAL_TRIALS trial_result · 2022-02-18Clinical Trial Update: Specified Drug-use Survey of the Granular Capsule Formulation of Omega-3 Fatty Acid Ethyl Esters: OCEAN3
A completed clinical trial update for the granular capsule omega-3 fatty acid ethyl esters (OCEAN3) surveying specified drug use in hyperlip…
-
FDA approval · 2022-02-08FDA Approved: ROSUVASTATIN CALCIUM — Supplemental Application (Zhejiang Yongtai Pharmaceutical Co., Ltd.)
FDA approved a supplemental application for Rosuvastatin Calcium from Zhejiang Yongtai Pharmaceutical Co., Ltd., resulting in an approved su…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-02-02FDA Approved: EZETIMIBE AND SIMVASTATIN — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for the ezetimibe and simvastatin combination product. This action updates the product's labeling fo…
-
FDA approval · 2022-01-28FDA Approved: COLESEVELAM HYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved a supplemental application for Colesevelam hydrochloride by Glenmark Pharmaceuticals Inc., USA, resulting in approved chang…
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: A Clinical Trial to Evaluate the Efficacy and Safety of Olmesartan/Amlodipine/Rosuvastatin Combination Treatment in Patients With Concomitant Hypertension and Hyperlipidemia [Phase 3]
A Phase 3 clinical trial completed evaluating the efficacy and safety of a fixed-dose olmesartan/amlodipine/rosuvastatin combination for pat…
-
FDA approval · 2022-01-04FDA Approved: FENOFIBRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for fenofibrate from Mylan Pharmaceuticals, updating an approved generic product.
-
FDA approval · 2021-12-22FDA Approved: LEQVIO — Original Application (Novartis Pharmaceuticals Corporation)
FDA granted original approval for LEQVIO (inclisiran) from Novartis Pharmaceuticals Corporation. The drug lowers LDL cholesterol in adults w…
-
FDA approval · 2021-12-10FDA Approved: GEMFIBROZIL — Supplemental Application (Cadila Pharmaceuticals Limited)
The FDA approved a supplemental application from Cadila Pharmaceuticals Limited for Gemfibrozil, finalizing approval of a generic version un…
-
CLINICAL_TRIALS trial_result · 2021-12-10Clinical Trial Update: Evaluation of Common Bean Baked Snack Consumption on Blood Lipids in Overweight People With Altered Blood Lipid Levels [Phase 2]
Phase 2 clinical trial evaluating common bean baked snack consumption on blood lipid levels in overweight individuals with dyslipidemia; stu…
-
FDA approval · 2021-12-10FDA Approved: GEMFIBROZIL — Supplemental Application (Zydus Lifesciences Limited)
The FDA approved a supplemental application for Gemfibrozil from Zydus Lifesciences Limited. This approval updates the existing ANDA for Gem…
-
FDA approval · 2021-11-30FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for atorvastatin calcium (generic atorvastatin) from Rising Pharma Holdings, Inc., confirming approv…
-
FDA approval · 2021-11-29FDA Approved: FENOFIBRIC ACID — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved the supplemental application for Fenofibric Acid submitted by Lupin Pharmaceuticals, Inc. This action approves a supplemental s…
-
FDA label_change · 2021-11-16FDA Approved: FENOFIBRATE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for fenofibrate from Apotex Corp., resulting in a label change for the generic product.
-
CLINICAL_TRIALS trial_result · 2021-10-27Clinical Trial Update: Effect of Red Yeast Rice Beside Statin on Lipid Profile [Phase 4]
Phase 4 trial evaluating the effect of red yeast rice in addition to statin therapy on lipid profile in hyperlipidemia patients completed.
-
FDA approval · 2021-10-20FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Welchol (colesevelam hydrochloride) submitted by Cosette Pharmaceuticals, Inc. to update the…
-
FDA approval · 2021-09-20FDA Approved: FENOFIBRATE — Original Application (Aurobindo Pharma Limited)
FDA approves the original application for generic fenofibrate by Aurobindo Pharma Limited.
-
FDA approval · 2021-09-15FDA Approved: EZETIMIBE AND SIMVASTATIN — Supplemental Application (Amneal Pharmaceuticals NY LLC)
The FDA approved a supplemental application for the ezetimibe and simvastatin combination product from Amneal Pharmaceuticals NY LLC.
-
FDA approval · 2021-09-14FDA Approved: CHOLESTYRAMINE — Supplemental Application (Ajanta Pharma USA Inc.)
The FDA approved a supplemental application for cholestyramine filed by Ajanta Pharma USA Inc., indicating an update to the product's approv…
-
FDA approval · 2021-08-31FDA Approved: SIMVASTATIN — Supplemental Application (XLCare Pharmaceuticals Inc.)
The FDA approved a supplemental application for simvastatin submitted by XLCare Pharmaceuticals Inc., approving changes under the ANDA.
-
FDA approval · 2021-07-14FDA Approved: ATORVASTATIN CALCIUM — Original Application (Dr. Reddy's Laboratories Inc)
The FDA approved Dr. Reddy's Laboratories' atorvastatin calcium as a generic tablet under an Original Application (ANDA214659), authorizing …
-
CLINICAL_TRIALS trial_result · 2021-07-07Clinical Trial Update: Stop Atherosclerosis in Native Diabetics Study [Phase 4]
Phase 4 trial update for a study aimed at stopping atherosclerosis in native diabetics; results completed with posting in 2021.
-
CLINICAL_TRIALS trial_result · 2021-06-10Clinical Trial Update: Is Treatment of Vitamin D Deficiency Associated With Resolution of Statin-Induced Muscular Symptoms [Phase 4]
Phase 4 trial investigating whether treating vitamin D deficiency resolves statin-induced muscular symptoms.